BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7958621)

  • 1. Relaxin: structures, functions, promises, and nonevolution.
    Schwabe C; Büllesbach EE
    FASEB J; 1994 Nov; 8(14):1152-60. PubMed ID: 7958621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of relaxin properties into other hormones of insulin-like structure.
    Büllesbach EE; Schwabe C
    SAAS Bull Biochem Biotechnol; 1996; 9():63-8. PubMed ID: 8652134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern.
    Büllesbach EE; Schwabe C
    Biochem Biophys Res Commun; 1993 Oct; 196(1):311-9. PubMed ID: 8216305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional importance of the A chain loop in relaxin and insulin.
    Büllesbach EE; Schwabe C
    J Biol Chem; 1994 May; 269(18):13124-8. PubMed ID: 8175738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for the interaction of sheep insulin-like factor 3 with relaxin receptors in rat atria.
    Tan YY; Dawson NF; Kompa AR; Bond CP; Claasz A; Wade JD; Tregear GW; Summers RJ
    Eur J Pharmacol; 2002 Dec; 457(2-3):153-60. PubMed ID: 12464361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
    Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
    Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
    Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
    Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relaxin peptide family--structure, function and clinical applications.
    Chan LJ; Hossain MA; Samuel CS; Separovic F; Wade JD
    Protein Pept Lett; 2011 Mar; 18(3):220-9. PubMed ID: 20858209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of relaxin-3/INSL7 as a ligand for GPCR142.
    Liu C; Chen J; Sutton S; Roland B; Kuei C; Farmer N; Sillard R; Lovenberg TW
    J Biol Chem; 2003 Dec; 278(50):50765-70. PubMed ID: 14522967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin: an insulin-related growth factor.
    Niall HD; Bradshaw RA; Bryant-Greenwood GD
    Prog Clin Biol Res; 1979; 31():651-8. PubMed ID: 395538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
    Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
    Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin-like bioactivity of ovine Insulin 3 (INSL3) analogues.
    Claasz AA; Bond CP; Bathgate RA; Otvos L; Dawson NF; Summers RJ; Tregear GW; Wade JD
    Eur J Biochem; 2002 Dec; 269(24):6287-93. PubMed ID: 12473125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid phase synthesis and structural analysis of novel A-chain dicarba analogs of human relaxin-3 (INSL7) that exhibit full biological activity.
    Hossain MA; Rosengren KJ; Zhang S; Bathgate RA; Tregear GW; van Lierop BJ; Robinson AJ; Wade JD
    Org Biomol Chem; 2009 Apr; 7(8):1547-53. PubMed ID: 19343240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants.
    Eigenbrot C; Randal M; Quan C; Burnier J; O'Connell L; Rinderknecht E; Kossiakoff AA
    J Mol Biol; 1991 Sep; 221(1):15-21. PubMed ID: 1656049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural contribution of the A-chain loop in relaxin.
    Büllesbach EE; Schwabe C
    Int J Pept Protein Res; 1995; 46(3-4):238-43. PubMed ID: 8537177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin.
    Schwabe C; Büllesbach EE
    Comp Biochem Physiol B; 1990; 96(1):15-21. PubMed ID: 2194740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single chain peptide agonists of relaxin receptors.
    Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
    Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin: a disulfide homolog of insulin.
    Schwabe C; McDonald JK
    Science; 1977 Aug; 197(4306):914-5. PubMed ID: 887933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.